Received February 5, 1985; accepted February 4, 1986. lease their granular content in a manner similar to that of nerve terminals. The aim of the present study was to determine whether platelet reactivity was altered in spontaneously hypertensive rats (SHR) and, if so, whether this alteration existed at the prehypertensive stage. In addition, we compared the functional response of platelets from hypertensive and control Wistar-Kyoto rats (WKY) to different external calcium concentrations to define the mechanism (or mechanisms) involved in the difference.
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Finally, since Mg 2+ possesses vasorelaxant properties, demonstrated on the whole animal 3 -4 as well as on isolated smooth muscle, 5 ' 6 and also decreases neuronal release, 7 and since its administration has been shown to exert a small hypotensive action, 8 
"
10 we tested its properties on platelets from SHR and WKY to determine whether its action was direct or mediated by Ca 2+ .
Materials and Methods
Okamoto strain SHR and age-matched normotensive WKY were obtained from Iffa Credo (Les Oncins, France). All experiments were performed on 11-weekold male rats, except for the dose-response curve to thrombin, which was also established in the prehypertensive state in platelets from 3-week-old rats. Mean systolic blood pressure, measured using tail-cuff methods, was 169 ± 3 mm Hg for SHR and 125 ± 2 mm Hg for WKY at 11 weeks of age and 105 ± 4 mm Hg for SHR and 95 ± 4 mm Hg for WKY at 3 weeks of age.
The rats were anesthetized with pentobarbital (40 mg/kg), and blood samples of 10 ml and 5 ml, respectively, for the adult and young animals were collected by carotid catheterization using citrate solution. Platelet rich plasma was obtained by centrifugation (2250 g for 90 seconds) and then diluted in plasma to reach a concentration of 10 8 cells/ml. This platelet suspension was incubated at 37°C with [ 3 H]serotonin (10-* M) for 5 minutes, then centrifuged twice at 450 g for 25 minutes. The washing buffer" used for the second centrifugation contained only 0.3% bovine serum albumin as a protective agent. All centrifugations were performed at 20 °C.
The SHR have more platelets than do WKY; however, the platelet content in endogenous serotonin is similar in both species, as are the kinetic constants of [ 3 H]-5-hydroxytryptamine (5-HT) uptake. 12 Therefore, the 5-HT contents after standardization of the cell concentration in platelet rich plasma from both strains appeared analogous. The washing procedure led to a great loss of cells (50%) but did not significantly modify the cellular radioactivity (the 3 H-platelet contents measured before and after the washing procedure were 164 ± 2 1 and 170 ± 2 5 , 176 ± 1 9 and 188 ± 2 6 pmol/10 8 platelets in preparations from WKY and SHR, respectively). Thus, no between-species differences in platelets appeared to be induced by this washing procedure.
The cells were then resuspended (10 7 platelets/ml) in 7V-2-hydroxyethylpiperazine-yV'-2-ethanesulfonic acid buffer," pH 7.4, containing 10~* M chlorimipramine to prevent any reuptake of the released [ 3 H]5-HT and various external Mg 2+ and Ca 2+ concentrations. The experiments were performed at 30 °C with minimal stirring. Thrombin was added after a 10-minute equilibration period, and the release reaction was stopped at 1, 3, 5, 10, and 15 minutes by adding icecold saline solution containing 1.8% formaldehyde. The platelet suspension was filtered (pore diameter, 0.22 /xm; Sartorius filters, Gottingen, FRG), and the remaining radioactivity was measured on the filters. The washed platelets were in a satisfactory functional state, as they correctly responded to several doses of thrombin (from 0.1 up to 1 U/ml) in aggregative conditions (i.e., at 37°C with an agitation of 1200 rpm in a dual spectroaggrometer; Coultronics, Paris, France The initial velocity of the reaction was calculated from the secretion measured during the first 3 minutes of incubation, and the dose-response curve of the platelets from SHR was shifted to the left (Figure lc) , illustrating the greater sensitivity of these platelets to the agonist. Furthermore, when maximal secretion (measured after a 15-minute incubation) was plotted against the initial velocity of the reaction ( Figure Id) , the curve from SHR exhibited a distortion when compared with that of the WKY. This finding suggests that some cellular event leading to secretion is also more active in platelets from SHR than in those from controls.
Platelets from young animals also responded differently to thrombin: platelets from SHR were significantly more reactive than those of WKY (Table 1) . On the other hand, platelets from adult Wistar rats behaved like those from WKY: thrombin, 0.2 and 0.3 U/ml, respectively, released 26.1 and 41.8% of the initial load of [ 3 H]5-HT during the first 3 minutes of incubation with these platelets.
Thrombin-induced secretion of 5-HT appears to depend on Ca 2+ concentration ( Figure 2 ). Suppression of external Ca 2+ by the addition of 10" 3 M EGTA decreased 5-HT secretion in platelets from both strains. Although this decrease was greater in platelets from SHR, these cells still secreted an appreciable amount of 5-HT under such conditions, whereas the platelet response in WKY to the same low concentration of thrombin (0.2 U/ml) was very slight.
Addition of 2 X 10~3 M Ca 2+ stimulated 5-HT secretion in platelets from both SHR and WKY. This response affected mainly the total amount of secreted 5-HT and did not abolish the magnitude of difference In the presence of 10~3 M EGTA the functional difference between platelets from SHR and WKY de- The effect of Mg 2+ was also tested on the inhibitory action of prostaglandin E,, which is known to act through the stimulation of adenylate cyclase (Table 3 ). In the absence of any spontaneous secretion of serotonin, prostaglandin E, had to be tested on the thrombin-induced secretion; therefore, it was added to the platelet suspension 3 minutes before thrombin (0.3 U/ml). Prostaglandin E,, 10" 7 M, did not exert any effect on thrombin-induced secretion of serotonin in the absence of external Mg 2+ but decreased it (by about 30%) in the presence of 10" 3 M external Mg 2+ concen- 2+ exerts a physiological modulatory role that may be altered in SHR. The hyperreactivity to thrombin and ADP observed in our washed platelet preparation agrees with the hyperaggregability described in platelet rich plasma of SHR 13 and with the recently described increased aggregation of washed platelets from SHR in response to ADP and collagen.
FIGURE 1. Thrombin-induccd secretion of 5-hydroxytryptamine (5-HT) in platelets from WKY (a) and SHR (b). Thrombin was added at different concentrations: 0.1 (o), 0.2 (»), 0.3 (A), 0.4 (A), 0.6 (O), and 1 ( • ) . The initial velocity (VJ of the reaction (c) was calculated in the secretion measured after a 3-minute incubation with thrombin in platelets from WKY (9) and SHR (O). Maximal secretion measured after a 15-minute incubation with thrombin (d) was plotted against the V t in platelets from WKY (•) and SHR (o). Each point is the mean
14 The multiplicity of the agonists strongly suggests that the platelet hyperreactivity in SHR is not linked to any anomaly of agonist receptors. As this platelet hyperreactivity in SHR was observed in the absence of plasma, it seems to reflect a cellular defect. However, it could be linked to the enduring effect of a circulating agent such as the endogenous N a + , K + -adenosine 5'-triphosphatase (ATPase) inhibiting factor, which has been shown to exist in hypertensive humans." This factor, whose existence was not demonstrated in SHR, 16 would first affect platelet serotonin active uptake. This uptake was indeed decreased in hypertensive humans 17 but not in SHR, 12 a finding that does not favor the hypothesis of the effect of such an endogenous factor on platelet release from SHR.
The hyperreactivity in platelets from SHR could conceivably be a consequence of the elevated blood pressure. This was not the case in the present study, since the same anomaly exists in the platelets of prehypertensive animals. The alteration of platelet function observed in SHR therefore appears to be linked to some cellular defect in this rat strain. Experiments performed in stroke-prone SHR, in both platelet rich plasma 18 and washed platelets, 19 did not provide the same results, however, and may reflect a different cellular alteration in this particular rat strain. 19 Judging from the evolution of the thrombin-induced secretion of 5-HT under the different Ca 2+ concentrations studied, it appears that platelets from SHR exhibit a greater sensitivity to a low Ca 2+ concentration (2 x 10" 6 M). This may result from an increased Ca 2+ permeability of the cell membrane, which may affect basal passive or thrombin-stimulated Ca 2+ influx. An increase in passive Ca 2+ influx was indeed observed in synaptosomes from SHR 20 and more recently in platelets from SHR.
14 The higher levels of free cytoplasmic Ca 2+ measured with the fluorescent indicator quin-2 in platelets 21 and lymphocytes from SHR 22 as well as in platelets from hypertensive patients" 23 may reflect this increased membrane permeability associated with reduced Ca 2+ storage or Ca 2+ extrusion capacity, as already described in other tissues from SHR. 24 As platelet secretion in SHR still occurred under weak stimulation in the presence of EGTA, it appears that external Ca 2+ is not the only factor involved in the difference in platelet reactivity between the two VOL 8, No 8, AUGUST 1986 groups. An alteration in intracellular Ca 2+ translocation may be involved, and the reduced Ca 2+ storage or extrusion already evoked again could explain this result. However, other factors might also be implicated. For example, in the absence of any increase in intracellular Ca 2+ concentration, 5-HT secretion may be induced by diacylglycerol produced by polyphosphoinositide breakdown. 23 The turnover of these polyphosphoinositides has been shown to be altered in erythrocyte membranes from SHR, 26 and our results may therefore reflect the same anomaly in platelets.
An inhibitory effect of external Mg 2+ on platelet activity has already been reported in other systems. In human platelets, 1 mM Mg 2+ potentiated the EGTA decrease in 5-HT secretion induced by the Ca 2+ ionophore A23187, 27 while the addition of Mg 2+ decreased the thrombin-induced activation of pig platelets. 28 External Mg 2+ also has been shown to decrease 5-HT release from superfused rat suprachiasmatic area, 7 and numerous studies have reported on the Mg 2+ -induced relaxation of smooth muscle cells.
3 " 6 Therefore, the difference between responses in WKY and SHR to external Mg 2+ observed in the present study may reflect a widespread anomaly of several cells in SHR.
The mechanism of this inhibitory effect of Mg 2+ appears to be complex. High concentrations of external Mg 2+ appear to suppress the 5-HT secretion induced by thrombin in the presence of a low Ca 2+ concentration (2 X 10" 6 M) in platelets from both species, as well as the ADP-induced and thrombin-induced secretion measured in the presence of high external Ca 2+ concentrations (2 x 10" 3 M) in platelets from WKY. An antagonistic action of Mg 2+ at the Ca 2+ channel level, as described in other tissues, 5 ' 29~31 may therefore also apply to platelets. This effect would be limited and overridden in platelets from SHR by the aforementioned increase in Ca 2+ permeability.
Nonetheless, the inhibitory effect of Mg 2+ was also observed in the absence of external Ca 2+ , which suggests the existence of a Mg 2+ -sensitive inhibitory system of platelet secretion. As such an inhibitory action of Mg 2+ has also been demonstrated in smooth muscle cells in the presence of EGTA, 29 this hypothetical inhibitory mechanism might be a rather general pathway of cell activation. In the range of Mg 2+ concentration activating this inhibitory system, the stimulation of 5-HT release induced by a high Ca 2+ concentration can be shown to increase with external Mg 2+ concentration in both species of platelets. This suggests that this Mg 2+ -sensitive mechanism would then be overridden by a high Ca 2+ concentration, as may the membrane Mg 2+ -dependent Ca 2+ -ATPase or cyclic nucelotide system. 32 The potentiating action of Mg 2+ on prostalandin E,-induced platelet inhibition favors an effect on cyclic nucleotide regulation, and Mg 2+ has been shown to play a crucial role in the regulation of hormonal inhibition of adenylate cyclase in human platelets. 33 Our comparison of platelets from SHR and WKY suggests that this inhibitory mechanism would be less sensitive to external Mg 2+ in platelets from SHR than in those from WKY (respective optimal concentrations of Mg 2+ : 2 x 10" 3 M and 10-3 M) and therefore less active in SHR at physiological extracellular Mg 2+ concentrations. This suggestion agrees with the reduction in membrane Ca 2+ -ATPase activity measured in various tissues from SHR 20 ' 24 and with the modifications in cyclic AMP metabolism described in platelets from SHR.
M Many enzymatic studies are needed to test these hypotheses, which, if demonstrated, would indicate that, as with the other important cations, Mg 2+ is involved in the dysfunction of cells from SHR, as suggested by Altura and Altura. 35 The low free internal Mg 2+ concentration recently measured in erythrocytes from hypertensive subjects 36 and the hypotensive action of Mg 2+ therapy suggest that this is also the case in humans.
